Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.36
-0.14 (-0.90%)
Sep 11, 2026, 4:08 PM HKT

Sinopharm Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
7,1557,0509,0548,5267,759
Depreciation & Amortization
4,0664,5294,2444,0023,783
Other Amortization
237.95201.88166.75147.53126.74
Loss (Gain) From Sale of Assets
-20.53-79.91-492.31-3.11-65.87
Asset Writedown & Restructuring Costs
591.541,10280.3695.7648.22
Loss (Gain) From Sale of Investments
2,2482,5682,6375,159930.13
Loss (Gain) on Equity Investments
-1,233-1,199-1,107-1,067-1,070
Provision & Write-off of Bad Debts
845.091,323614.54431.88445.77
Other Operating Activities
2,9992,5235,8415,7468,841
Change in Accounts Receivable
-7,775-17,369-14,850710.12-26,717
Change in Inventory
-1,106-2,040455.56-9,504-4,345
Change in Accounts Payable
7,4806,21810,7848,31519,805
Change in Unearned Revenue
-844.7553.42-3,9614,314-1,265
Change in Other Net Operating Assets
-506.436,1663,706-5,909421.26
Operating Cash Flow
14,13811,54617,17320,9649,308
Operating Cash Flow Growth
22.45%-32.77%-18.08%125.22%-16.55%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,496-1,471-1,960-2,127-2,074
Sale of Property, Plant & Equipment
19.2365.74456.13172.34134.01
Cash Acquisitions
--209.61-108.24-449.15-497.22
Divestitures
66.9124.9926.4481.186.12
Sale (Purchase) of Intangibles
-107.96-266.95-324.01-188.75-153.06
Sale (Purchase) of Real Estate
0.010.1828.820.631.14
Investment in Securities
83.268.56102.59-51.17-8.15
Other Investing Activities
470.47-1,962833.32-1,0281,324
Investing Cash Flow
-963.89-3,751-944.54-3,590-1,267

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
107,974106,926106,438106,45199,922
Total Debt Issued
107,974106,926106,438106,45199,922
Long-Term Debt Repaid
-120,871-116,861-106,052-103,530-106,464
Lease Payments
-1,986-2,204-2,116-1,825-1,757
Total Debt Repaid
-120,871-116,861-106,052-103,530-106,464
Net Debt Issued (Repaid)
-12,898-9,935385.682,921-6,543
Common Dividends Paid
-2,122-2,715-2,559-2,340-2,153
Other Financing Activities
-3,667-4,635-5,471-6,274-5,997
Financing Cash Flow
-18,687-17,285-7,644-5,693-14,693

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-4.9-5.242.3911.513.05
Net Cash Flow
-5,517-9,4958,58711,692-6,649

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
12,64210,07515,21318,8377,234
Free Cash Flow Growth
25.49%-33.78%-19.23%160.38%-21.85%
Free Cash Flow Margin
2.20%1.72%2.55%3.41%1.39%
Free Cash Flow Per Share
4.053.234.886.042.32
Levered Free Cash Flow
2,775-6,91710,15815,174-2,358
Unlevered Free Cash Flow
4,208-5,21412,00017,368-17.52
Free Cash Flow After Leases
10,6567,87013,09817,0125,477

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2,4743,3223,1994,7784,575
Cash Income Tax Paid
4,7414,4564,5754,3994,074
Change in Working Capital
-2,752-6,471-3,864-2,074-12,101